Validation and cross-cultural adaptation of the Sarcopenia Disease Risk Perception Scale among Turkish older adults Authors: Hatice Betigul Meral, Sena Tolu, Zeynep Noyan Published: 2026 ABSTRACT ObjectivesThis study aims to determine the validity and reliability of the Turkish version of the Sarcopenia Disease Risk Perception Scale (SDRPS-TR), addressing the lack of disease-specific risk perception tools in Türkiye.Patients and methodsThe validation process was conducted in two phases: (i) translation and cross-cultural adaptation of the SDRPS into Turkish and (ii) psychometric evaluation of the SDRPS-TR. A total of 323 Turkish individuals (132 males, 191 females; mean age: 71.6±7.8 years; range, 60 to 93 years) were included between December 2024 and January 2025. Content validity was assessed using the content validity index. Construct validity was evaluated through exploratory factor analysis and confirmatory factor analysis. Reliability was assessed by measuring internal consistency (Cronbach’s alpha), test-retest reliability (intraclass correlation coefficient, ICC), and split-half reliability (Spearman-Brown coefficient).ResultsContent validity index values ranged between 0.85 and 1.00, confirming strong content validity. Exploratory factor analysis identified a two-factor structure (perceived susceptibility and perceived severity), explaining 55.8% of the variance. Confirmatory factor analysis confirmed the model fit with acceptable indices. The SDRPS-TR demonstrated high internal consistency (Cronbach’s alpha=0.929) and excellent test-retest reliability (ICC=0.844, 95% confidence interval 0.764-0.907).ConclusionThe SDRPS-TR is a valid and reliable instrument for measuring sarcopenia risk perception among Turkish older adults. The availability of SDRPS-TR provides important opportunities for the early identification of at-risk individuals. It also supports clinical screening and community-based health education efforts, contributing to timely intervention for sarcopenia. Sarcopenia is defined as a gradual decline in skeletal muscle mass, strength, and functionality, usually commencing in adulthood. The etiology includes age-associated neuronal degeneration, decreased levels and sensitivity of anabolic hormones, dysregulation of inflammatory mechanisms, and cytokine secretion abnormalities.[1] Specifically, changes in growth hormone, corticosteroids, androgens, and estrogens disturb the equilibrium between muscle protein production and breakdown, resulting in compromised muscle integrity. These basic pathways are crucial in the initiation and progression of sarcopenia. Sarcopenia in older adults is linked to numerous health complications, such as heightened fall risk, impaired mobility, cardiovascular disorders, physical disability, elevated morbidity and mortality rates, and reliance on long-term care. Moreover, it may lead to cognitive deterioration and reduced quality of life.[2] Sarcopenia also elevates the risk of hospitalization and overall death rates in elderly individuals undergoing inpatient treatment.[3] Factors such as physical fatigue, restricted mobility, and malnutrition during hospitalization contribute to the development and escalation of sarcopenia. Thus, a bidirectional link between sarcopenia and hospitalization has been proposed.[4] The term sarcopenia was first presented by Irwin Rosenberg in 1989 and was originally defined only as a loss of muscle mass due to aging. However, in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) asserted that, with low muscle mass, diminished muscle strength and physical performance must also be regarded as essential diagnostic criteria. In the 2018 update (EWGSOP2), low muscle strength was recognized as the main sign of sarcopenia, and the significance of including muscle quantity/quality and physical performance assessments to evaluate disease severity was emphasized.[5, 6] Defined with the ICD-10 (International Statistical Classification of Diseases and Related Health Problems 10th Revision) code M62.84 in 2016, sarcopenia is classified among musculoskeletal diseases and is clinically recognized as a muscle disorder, being identified not only in older adults but also in younger individuals and those with chronic conditions. In 2019, the Asian Working Group for Sarcopenia revised its diagnostic algorithm to facilitate early detection and intervention in primary healthcare settings, introducing the concept of “possible sarcopenia.”[7] The prevalence of sarcopenia increases with age. Sarcopenia is believed to affect 13 to 14% of those under 70 years of age, but its prevalence surpasses 50% in those over 80 years old.[8] Notwithstanding the elevated prevalence rates, knowledge of sarcopenia remains significantly lower in comparison to other age-related illnesses.[9] A study employing Google Trends data indicated that public interest and online search frequency for sarcopenia were markedly inferior to those for osteoporosis or dementia.[10] This lack of awareness may stem from patients' unfamiliarity with the term "sarcopenia" or the prevalent belief that muscle loss is an unavoidable and normal consequence of aging. In studies conducted in Türkiye, one indicated a sarcopenia prevalence of 31.7%, with rates between 7 to 14% for persons aged 60 to 69 years and 50 to 63% for those aged ≥ 80 years.[11] These findings underscore the necessity for early risk evaluation and the implementation of effective preventative interventions customized to national demography. Various screening tools have been developed to assess an individual’s physical capacity and independence level. One of the most widely used questionnaires is the SARC-F (strength, assistance with walking, rising from a chair, climb stairs, and falls).[12] In 2017, Rossi et al.[13] introduced the Mini Sarcopenia Risk Assessment questionnaire and demonstrated its effectiveness in predicting sarcopenia risk. However, most screening tools do not directly assess the awareness of sarcopenia. These instruments, primarily used by healthcare professionals, are designed to identify individuals at risk of sarcopenia and guide the diagnostic process rather than measure individuals’ perceptions of the disease. Over time, various scales have been developed to evaluate individuals’ perceptions of the risks related to chronic diseases.[14, 15, 16] One of such tools, the Illness Perception Questionnaire, was developed by Weinmann et al.[17] in 1996 and has been adopted in Türkiye to assess perceptions of various chronic diseases. However, disease-specific risk-perception assessment tools are required. Existing literature highlight the importance of personalized scales that enable individuals assess their risk perceptions.[18, 19] Perception of risk is vital for increasing awareness, motivating people to embrace healthier habits, and fostering active participation in managing diseases. Moreover, it offers healthcare practitioners important information on early intervention and the formulation of preventive strategies.[19] The Sarcopenia Disease Risk Perception Scale (SDRPS) was created to evaluate the perception of sarcopenia risk among older adults. The scale was initially validated through a study carried out in China, showing its reliability and validity.[20] Formulated from literature reviews, expert insights, and initial surveys, the scale was evaluated on 438 Chinese participants aged ≥60 years employing a cross-sectional approach. The scale consists of 15 items split into two sections: eight items evaluating perceived susceptibility and seven items measuring perceived severity. The objective of this research was to adapt the SDRPS for the Turkish population and assess its psychometric characteristics, such as validity and reliability. PATIENTS AND METHODS This study was conducted at the Department of Physical Medicine and Rehabilitation of the İstanbul Medipol University Faculty of Medicine. Participants were consecutively recruited between December 2024 and January 2025. Inclusion criteria were as follows: (i) individuals aged ≥60 years and (ii) ability to communicate effectively. Exclusion criteria were as follows: (i) patients diagnosed with dementia, severe cognitive impairment, or psychiatric disorders that could hinder questionnaire completion; (ii) individuals with significant visual or hearing impairments that could interfere with their ability to read or understand the survey; and (iii) patients with severe comorbid conditions requiring immediate medical attention. These criteria were meticulously designed to guarantee that participants could comprehend and react appropriately to the survey questions. The study sought to improve the reliability and internal validity of the collected data by reducing factors that could hinder comprehension or introduce response bias. A total of 413 older persons, aged 60 to 93 years, who visited the outpatient physical medicine and rehabilitation clinic at a university hospital, were invited to participate in the study. Among the participants, 45 declined to provide informed consent; 12 had acute medical conditions; 18 had conditions that could interfere with questionnaire completion, such as severe visual or hearing impairments; nine had cognitive impairments, including dementia or severe psychiatric disorders; and six had comorbidities requiring urgent medical attention. After applying the exclusion criteria, the final sample comprised 323 participants (132 males, 191 females; mean age: 71.6±7.8 years; range, 60 to 93 years). Permission to use and adapt the SDRPS was obtained via e-mail from Zhang et al.,[20] the original developers. Written informed consent was obtained from all participants. The study protocol was approved by the İstanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Data: 13.12.2024, No: E-10840098-202.3.02-7691). The study was conducted in accordance with the principles of the Declaration of Helsinki. Translation and cultural adaptation In the first stage, the original scale was independently translated into Turkish by two bilingual translators. In the second stage, a consensus version (Version 1) was created by synthesizing these two translations. In the third stage, two bilingual translators, who were blinded to the original version, performed the back-translation into English. Expert review In terms of content validity, the Turkish-adapted version of the scale and the original English version were reviewed by a panel of 10 experts specializing in different fields relevant to the subject. The expert panel included three geriatric specialists, two physiotherapists, two internal medicine specialists, one public health specialist, and two academicians. Experts evaluated the scale in terms of cultural adaptation, clarity, and comprehensiveness for the Turkish population. During this process, the Davis technique was employed to calculate the content validity index (CVI), and experts were asked to rate the scale items on a 4-point scale (1=not appropriate; 2=needs modification to be appropriate; 3=useful but requires minor changes; 4=very appropriate).[21] To ensure clarity and cultural appropriateness, select items were revised using terminology familiar within the Turkish healthcare context, with approval from the original SDRPS developers. Ultimately, in the pretesting phase, the prefinal Turkish version (Version 2) was delivered to 10 older adults to evaluate their understanding and cultural relevance. The participants deemed the scale comprehensible, and no notable issues were identified. Based on their feedback, only minor linguistic refinements were made, leading to the final Turkish version of the SDRPS (SDRPS-TR). Psychometric evaluation The validity and reliability of the SDRPS-TR were assessed in two phases. Statistical analyses were conducted using IBM SPSS version 26.0 (IBM Corp., Armonk, NY, USA) for general statistical analysis and R software with the Lavaan package for confirmatory factor analysis (CFA). The Shapiro-Wilk test was used to assess the normality of continuous variables. Descriptive statistics are reported as mean ± standard deviation (SD) for normally distributed data and median (min-max) for nonnormally distributed data. Categorical variables were presented as frequencies and percentages. Phase 1: Assessment of internal consistency and test-retest reliability Internal consistency was assessed using the Cronbach’s alpha (α), with a value of ≥0.70 considered acceptable. More specifically, an α of ≥0.90 indicated excellent internal consistency, 0.80≤ α <0.90 indicated good consistency, and 0.70≤ α <0.80 indicated acceptable consistency.[22] Additionally, split-half reliability was evaluated using the Spearman–Brown coefficient to further assess the scale’s internal consistency. For test-retest reliability analysis, a sample size of at least 10% of the main sample was recommended, with a minimum of 30 participants. Accordingly, 50 participants completed the SDRPS-TR again after a two-week interval to assess test-retest reliability. Intraclass correlation coefficient (ICC) was used to measure the stability of the scale over time. Phase 2: Evaluation of construct and structural validity An exploratory factor analysis (EFA) was conducted to determine the scale factor structure. The Kaiser-Meyer-Olkin (KMO) test was used to assess sample adequacy, and Bartlett’s test of sphericity was used to determine whether the correlation matrix was suitable for factor analysis.[23] Principal component analysis with Varimax rotation was performed to extract factors, and items with factor loadings ≥0.50 were retained. Exploratory factor analysis identified a two-factor structure for the SDRPS-TR. The first factor (Factor 1) included items 1-8, representing perceived susceptibility, whereas the second factor (Factor 2) included items 9-15, representing perceived severity. Confirmatory factor analysis was conducted using R software (version 4.4.3; R Foundation for Statistical Computing, Vienna, Austria) with the lavaan package to assess the structural validity of the model. To evaluate model fit, multiple indices were examined. The chi-square to degrees of freedom ratio (CMIN/DF) was used to assess the relative discrepancy between the sample and model-implied covariance matrices. The root mean square error of approximation (RMSEA) is a noncentrality-based index estimating lack of fit per degree of freedom, considering model complexity and sample size. The goodness-of-fit index (GFI) represents the proportion of variance explained by the model relative to the observed data. The normed fit index (NFI) evaluates improvement over a null model in which all variables are assumed uncorrelated. The comparative fit index (CFI) and incremental fit index (IFI) also compare the target model to a null model, adjusting for degrees of freedom; both are less sensitive to sample size. All fit indices in the current analysis met conventional thresholds for acceptable model fit: CMIN/DF ≤ 5, RMSEA ≤ 0.08, GFI ≥ 0.90, NFI ≥ 0.90, CFI ≥ 0.90, and IFI ≥ 0.90.[24] Sample size and data collection A total of 323 older adults participated in this study. The sample size was determined based on the factor analysis requirements, with recommendations of five to 10 participants per item.[25] Because the SDRPS consists of 15 items, a minimum of 150 participants was required for the EFA, and at least 200 participants were required for the CFA. Additionally, a participant interview form was developed to collect sociodemographic data, including age, sex, educational level, marital status, and history of chronic disease. Trained healthcare professionals collected data face-to-face at an outpatient clinic. The participants independently completed the SDRPS-TR questionnaire, which was administered on the same day. The scale utilized a 5-point Likert scale with responses ranging from “strongly disagree” to “strongly agree,” scored from 1 to 5. Higher scores indicated a higher level of risk perception of sarcopenia among older adults. RESULTS Age distribution of the participants was as follows: 148 (45.8%) participants were aged between 60 and 69 years, 127 (39.3%) were between 70 and 79 years, 43 (13.3%) were between 80 and 89 years, and five (1.5%) were ≥90 years. Regarding educational level, 122 (37.8%) participants had completed primary school or below; 52 (16.1%) had a junior high school education; 60 (18.6%) had completed senior high school; and 89 (27.6%) had a college degree or higher. In terms of marital status, 10 (3.1%) participants were unmarried, 250 (77.4%) were married, 27 (8.4%) were divorced, and 36 (11.1%) were widowed. Detailed demographic characteristics of the study population are presented in Table 1. Psychometric validation analyses The SDRPS-TR was psychometrically validated through various statistical analyses, including internal consistency, test-retest reliability, EFAs, CFAs, and correlation assessments between the subscales. a) Content validity The CVI values for the scale items ranged from 0.85 to 1.00, indicating good content validity based on expert agreement regarding item clarity and relevance. According to the literature, a CVI >0.80 is generally considered acceptable for content validity.[21] Therefore, all items were deemed to have adequate content validity. The high CVI scores also suggest that the Turkish version of the scale successfully maintained the conceptual integrity of the original instrument while ensuring cultural and linguistic appropriateness. b) Internal consistency and reliability Internal consistency of the SDRPS-TR was evaluated using the Cronbach’s α, which was 0.929 for the entire scale, indicating excellent reliability. When examined separately, Factor 1 had a Cronbach’s α of 0.879, whereas Factor 2 had a Cronbach’s α of 0.870, both of which demonstrated high internal consistency. Additionally, split-half reliability, assessed using the Spearman-Brown coefficient, was 0.902 for the total scale, confirming strong internal structural stability, with a value of 0.862 for Factor 1 and 0.836 for Factor 2. To assess the test-retest reliability, 50 participants completed the SDRPS-TR twice, with a two-week interval between administrations. The ICC was 0.844 (95% confidence interval 0.764-0.907) for the total scale, indicating good temporal stability. When analyzed according to factor, Factor 1 had an ICC of 0.809, whereas Factor 2 had an ICC of 0.780, further supporting the scale’s consistency over time. Table 2 presents the reliability analysis, including internal consistency and test-retest statistics. c) Exploratory factor analysis An EFA was performed to explore the underlying factor structure of the SDRPS-TR. Sample adequacy was confirmed using the KMO test, which yielded a value of 0.962, indicating excellent suitability for factor analysis. The Bartlett’s test of sphericity was significant (χ²=2013.617, df=89, p<0.001), suggesting that the dataset was appropriate for factor extraction. Using principal component analysis with Varimax rotation, two factors that explained 55.8% of the total variance were identified. Factor loadings were between 0.469 and 0.789, confirming the structural validity of the SDRPS-TR (Table 3). The analysis confirmed a two-factor structure: perceived susceptibility (Items 1-8, explaining 28.5% of the variance) and perceived severity (Items 9-15, accounting for 27.3%), consistent with the original SDRPS. d) Confirmatory factor analysis Confirmatory factor analysis was conducted to evaluate the structural validity of the scale. The modified CFA model confirmed a two-factor structure, where Items s1-s8 were loaded onto Factor 1, and items s9-s15 loaded onto Factor 2. Factor loadings were between 0.64 and 0.73 for Factor 1 and 0.64 and 0.73 for Factor 2, demonstrating strong associations between the observed variables and their respective latent constructs. The correlation coefficient between Factor 1 and Factor 2 was 0.94, indicating a strong correlation between these two factors. According to the revised fit indices after modification, the RMSEA (0.028), GFI (0.957), NFI (0.952), CFI (0.990), and IFI (0.996) values indicated that the model fit was acceptable (Table 4). These findings support the validity and reliability of the proposed factor structure, suggesting that the scale was a robust measure of the targeted constructs. The standardized factor loadings and structural models are illustrated in Figure 1. The mean of the total scale scores was 40.97±8.19. The means of the subscale scores for perceived susceptibility and severity were 21.78±0.45 and 19.19±4.13, respectively. e) Construct validity Spearman’s correlation analysis was used to assess the relationship between the two extracted factors, with a correlation coefficient of r=0.647 and p<0.001, indicating a moderately positive correlation. This suggests that although the two factors measure distinct constructs of risk perception, they remained related in terms of sarcopenia awareness. f) Floor and ceiling effects Floor and ceiling effects were not observed. DISCUSSION This study aimed to evaluate the psychometric properties of the SDRPS-TR in older adults. The results demonstrated that the scale has excellent internal consistency, good test-retest reliability, and consistent construct validity, with no floor or ceiling effects. These findings indicate that the SDRPS-TR is a reliable and valid tool for assessing sarcopenia risk perception among the Turkish older adult population. Illness perception denotes the manner in which individuals comprehend a condition and how this comprehension impacts their health-related behaviors and treatment approaches.[26] Sarcopenia is prevalent in older persons and can result in considerable clinical consequences; nevertheless, there is a lack of disease-specific instruments to evaluate awareness and risk perception. A recent study by Bullock et al.[27] shown that older cancer patients typically possessed low awareness of sarcopenia; the majority of participants were unfamiliar with the term and saw muscle loss as a natural aspect of aging. A national survey in Australia revealed that while most primary healthcare physicians recognized the clinical significance of sarcopenia, hardly 23% said that they undertook routine screening.[28] A comprehensive analysis by Lewis et al.[29] corroborated similar findings, revealing significant gaps in sarcopenia awareness among patients, healthcare professionals, and the general populace across diverse countries and communities. These findings emphasize the necessity for culturally tailored assessment instruments, such as the SDRPS-TR, to enhance awareness, early identification, and risk perception of sarcopenia in clinical practice. Supporting this need at the national level, Erkoyun and Uçku[30] conducted the first community-based study in Türkiye to evaluate sarcopenia risk using a representative sample. Their findings revealed that nearly half of individuals aged 65 to 79 years living in the Balçova district of İzmir had low grip strength and slow gait speed, and approximately one-third exhibited both conditions simultaneously. This highlights the need to assess sarcopenia risk perception and promote early awareness in the Turkish older adult population. In segments of the population where risk factors such as low educational attainment, physical inactivity, and malnutrition are prevalent, a culturally adapted tool that enables individuals to evaluate their own risk perception may serve as a valuable means to encourage preventive health behaviors. The SDRPS was translated and culturally adapted in collaboration with the original developers. Expert reviews and pilot testing ensured its suitability for the Turkish older population. Exploratory factor analysis was conducted to examine the underlying structure of the SDRPS-TR. The KMO value was 0.962, indicating excellent sampling adequacy slightly exceeding the original scale’s value (0.917).[20] All 15 items were retained in our analysis, with factor loadings ranging from 0.469 to 0.789. Researchers accept loadings above 0.30 as acceptable, and those exceeding 0.60 as high. Kaiser-Meyer-Olkin values close to 1 suggest a strong fit with the factorial model, whereas values below 0.60 are considered moderate.[31, 32] These results indicate that the Turkish version of the scale had a strong factor structure. Confirmatory factor analysis yielded strong fit indices (χ²/df = 1.164, RMSEA = 0.028, GFI = 0.957, NFI = 0.952, CFI = 0.990, and IFI = 0.996), indicating that the two-factor structure of the SDRPS-TR is both statistically significant and consistent with the theoretical model. These findings support the structural validity of the scale.[33, 34] There is a limited number of studies in the literature evaluating patients’ perceptions and knowledge regarding sarcopenia. In a multicenter cross-sectional study conducted by Zhao et al.,[35] hemodialysis patients were found to have generally low levels of knowledge regarding sarcopenia, while their awareness of its physical consequences was relatively higher. Specifically, the item stating that “Sarcopenia increases the risk of falls, fractures, and cardiovascular disease” had the highest correct response rate, with 47.19% of participants responding accurately. Similarly, a community-based study from South Korea reported that individuals’ perceptions of sarcopenia were predominantly influenced by its physical consequences, such as falls, muscle weakness, and impaired mobility.[36] In our study, the items “risk of falling” and “risk of fracture” also demonstrated strong loadings under the perceived severity factor, consistent with the original version of the scale. This consistency suggests that the physical signs of sarcopenia are more easily identified by patients and may act as a substantial motivator for behavioral adjustment. Therefore, emphasizing these specific risks in public health messaging may enhance the effectiveness of sarcopenia prevention strategies. In 2023, Lee et al.[37] developed the Sarcopenia Knowledge Questionnaire to assess older adults’ knowledge of sarcopenia across three domains: screening and diagnosis, sarcopenia-related outcomes, and lifestyle factors. A research in the Netherlands by Verstraeten et al.[38] revealed that merely 3.2% of elderly rehabilitation inpatients were familiar with the term sarcopenia, while 63.5% recognized the need of sufficient protein consumption for muscle health. In our study, the item stating that “insufficient nutritional intake increases the risk of sarcopenia” demonstrated the highest loading within the perceived susceptibility domain. This finding indicates that nutritional beliefs represent a core component of this construct and that participants tend to conceptualize sarcopenia risk in terms of concrete and modifiable factors. Therefore, nutrition-focused messaging may serve as an accessible entry point for shaping sarcopenia risk perception and facilitating more active engagement among older adults. In our study, the item “sarcopenia increases the burden of family care” had the highest factor loading within the perceived severity domain. A similar finding highlighting the importance of caregiving burden was reported in the World Health Organization’s World Mental Health Surveys conducted across 19 countries. According to these surveys, 39.0 to 39.6% of individuals with a first-degree relative suffering from a significant physical or mental illness experienced some form of caregiving burden, with psychological distress being the most commonly reported component (23.3-27.1%).[39] In collectivist societies like Türkiye, where interdependence and familial obligations are esteemed, individuals may prioritize the effects of disease on their family members more significantly. The fear of being a burden can serve as a substantial emotional impetus, leading patients to perceive their illness as more serious and to adopt preventive health measures. Consequently, creating health education programs that emphasize the personal consequences of sarcopenia and its potential effects on familial relationships may enhance the effectiveness of these therapies. The SDRPS-TR scale enables healthcare professionals to identify individuals with little awareness or misconceptions regarding sarcopenia risk, facilitating timely educational and behavioral interventions. A reduced sense of danger may negatively impact individuals' participation in preventive health measures, such as regular physical activity, adequate nutritional intake, and involvement in screening programs. Public health authorities can utilize the SDRPS-TR to monitor trends in sarcopenia risk perception among the aging population and to develop suitable community-based awareness campaigns or intervention initiatives. This tool may aid in mitigating functional loss associated with sarcopenia by encouraging the prompt implementation of lifestyle changes as part of healthy aging initiatives. This study had several limitations. Initially, participants were not classified according to their sarcopenia status. Dividing the sample into sarcopenic and nonsarcopenic groups could have facilitated a more in-depth examination of the scale's discriminatory validity and clinical significance. Moreover, this study did not assess predictive validity in relation to confirmed sarcopenia or clinical outcomes. In conclusion, this study fills a crucial gap by providing a validated measure of sarcopenia risk perception tailored to the Turkish older adult population. While the SDRPS-TR shows strong reliability and construct validity, future research should focus on its predictive value and adaptability across diverse cultural and clinical contexts.